课题基金 / 基金详情

Crystallographic Analysis of NMN Adenylytransferases

Crystallographic Analysis of NMN Adenylytransferases
NMN 腺苷酸转移酶的晶体学分析
批准号:
6752498
负责人:
HONG ZHANG
金额:
$19.5万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-06-15 至 2006-05-31

项目摘要

项目成果

HONG ZHANG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (provided by applicant) Nicotinamide mononucleotide adenylyltransferase (NMNAT) is an indispensable enzyme in the biosynthesis and salvage of NAD and NADP in all living organisms. In prokaryotes, it is absolutely required for cell survival, thus representing an attractive target for designing new broad-spectrum anti-infectious pharmaceutics. There is also considerable medical interest in human NMNAT because it catalyzes the key step in the metabolic conversion of the antitumor drug tiazofurin to its active form, tiazofurin adenine dinucleotide (TAD). Because of the vital roles of NAD in the cell, adequate levels of NAD must be maintained. In bacteria, a single protein NadR performs multiple functions in response to the cellular NAD and ATP levels. These include a transcriptional repressor, a NMN adenlyltransferase, and a nicotinamide ribose kinase. NadR regulates the expression of the genes involved in both de novo biosynthesis and savage of NAD. It also controls the uptake of NMN and its subsequent adenylation. Structural information of NMNAT and NadR, along with their complexes with substrates will be essential for understanding the catalysis, substrate recognition, inhibition, as well as regulation of these important enzymes. We have solved the crystal structure of the first bacterial NMNAT in its ligand free form and have obtained well diffracting human NMNAT crystals. Comparison of the bacterial and human enzyme structures will help to design specific bacterial inhibitors with high selectivity. Additionally, we have expressed and purified NadR proteins from S. typhimurium and H. influenzae, and the crystallization trials are in progress. Elucidating the structures of NadR in its various ligand-bound forms and its complex with DNA will reveal how its conformation and function are modulated by both NAD and ATP.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LONGITUDINAL ANALYSIS OF HIV-1 CLADE C FITNESS
  • 批准号:
    7959389
  • 项目类别:
  • 资助金额:
    $17.07万
  • 财政年份:
    2009
  • 负责人:
    HONG ZHANG
  • 依托单位:
Anastomotic Device for Large Vascular Grafts
  • 批准号:
    7671280
  • 项目类别:
  • 资助金额:
    $9.97万
  • 财政年份:
    2009
  • 负责人:
    HONG ZHANG
  • 依托单位:
LONGITUDINAL ANALYSIS OF HIV-1 CLADE C FITNESS
  • 批准号:
    7719946
  • 项目类别:
  • 资助金额:
    $17.06万
  • 财政年份:
    2008
  • 负责人:
    HONG ZHANG
  • 依托单位:
LONGITUDINAL ANALYSIS OF HIV-1 CLADE C FITNESS
  • 批准号:
    7609838
  • 项目类别:
  • 资助金额:
    $17.91万
  • 财政年份:
    2007
  • 负责人:
    HONG ZHANG
  • 依托单位:
国内基金
海外基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    潘寒姁
  • 依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    朱慧媛
  • 依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    孙爱东
  • 依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘玉兰
  • 依托单位: